Market Overview

Aegis Capital Initiates Coverage on China Cord Blood Corporation. at Buy, Announces $5.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CO

DateFirmActionFromTo
Feb 2016Scotia Howard WeilDowngradesOutperformSector Perform
Aug 2015JefferiesMaintainsBuy
Jun 2015Roth CapitalDowngradesBuyNeutral

View More Analyst Ratings for CO
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CO)

Get Benzinga's Newsletters